Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Soochow University115 Second Affiliated Hospital of Soochow University16 Capital Medical University9 Novartis Pharmaceuticals8 Takeda7 Wecare Probiotics Co., Ltd.7 Amgen6 Children's Hospital of Soochow University6 AbbVie6 BeOne Medicines5 PersonGen BioTherapeutics (Suzhou) Co., Ltd.5 Sanofi5 Eli Lilly and Company5 The First Affiliated Hospital with Nanjing Medical University4 Pfizer4 Suzhou Municipal Hospital4 Merck Sharp & Dohme LLC4 Ascentage Pharma Group Inc.4 Shanghai Zhongshan Hospital4 Huashan Hospital4 Zhao Jun3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3 Shanghai Jiao Tong University School of Medicine3 Peijia Medical Technology (Suzhou) Co., Ltd.3 First Affiliated Hospital of Zhejiang University3 GlaxoSmithKline3 Janssen Research & Development, LLC3 AstraZeneca3 UCB Biopharma SRL3 Chen Suning2 Hangzhou Sumgen Biotech Co., Ltd.2 Suzhou Municipal Hospital of Anhui Province2 Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd2 Triastek, lnc.2 Karyopharm Therapeutics Inc2 GeneCradle Inc2 Tasly Pharmaceutical Group Co., Ltd2 Changhai Hospital2 Innovent Biologics (Suzhou) Co. Ltd.2 Zhangjiagang First People's Hospital2 PharmaEssentia2 Sheng-Li Xue, MD2 Nanjing RegeneCore Biotech Co., Ltd.2 Yunhe Pharmaceutical (Tianjin) Co., Ltd2 Bristol-Myers Squibb2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2 Dushu Lake Hospital Affiliated to Soochow University2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Novo Nordisk A/S2 Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2 Jiangsu Topcel-KH Pharmaceutical Co., Ltd.2 Soochow University2 Celgene2 Astellas Pharma Global Development, Inc.2 Suzhou Hengruihongyuan Medical Technology Co. LTD2 Sinomune Pharmaceutical Co., Ltd1 UCARsgen Biotech Limited1 Allist Pharmaceuticals, Inc.1 Abbisko Therapeutics Co, Ltd1 First Hospital of China Medical University1 H. Lundbeck A/S1 Simcere Pharmaceutical Co., Ltd1 The Fourth Affiliated Hospital of Soochow University1 Atom Therapeutics Co., Ltd1 Xuanwu Hospital, Beijing1 Xiyuan Hospital of China Academy of Chinese Medical Sciences1 Beijing InnoCare Pharma Tech Co., Ltd.1 Hangzhou PhecdaMed Co., Ltd.1 Chunshui He1 Angitia Biopharmaceuticals Guangzhou Limited1 Starna Therapeutics1 Beeline Medicines Corporation1 EMD Serono Research & Development Institute, Inc.1 Shanghai Jiatan Pharmatech Co., Ltd1 The First Affiliated Hospital of Dalian Medical University1 Beijing Tiantan Hospital1 Healthguard Biomed1 Chongqing Precision Biotech Co., Ltd1 Zhejiang Teruisi Pharmaceutical Inc.1 Akeso1 Du Zhenggui1 The Second Hospital of Anhui Medical University1 Institut de Recherches Internationales Servier1 First Affiliated Hospital of Wannan Medical College1 Nanjing Legend Biotech Co.1 Tianjin Medical University General Hospital1 Wenjun Cheng1 Gracell Biotechnologies (Shanghai) Co., Ltd.1 Children's Hospital of Fudan University1 SyMap Medical (Suzhou), Ltd.1 China Medical University, China1 Beijing Anzhen Hospital1 Alexion Pharmaceuticals, Inc.1 The Children's Hospital of Zhejiang University School of Medicine1 Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.1 Chengdu Zenitar Biomedical Technology Co., Ltd1 magAssist, Inc.1 IVIEW Therapeutics Inc.1 Sellas Life Sciences Group1 Suzhou Centergene Pharmaceuticals Co.,Ltd.1 Wellizen Australia1 Hrain Biotechnology Co., Ltd.1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 Fudan University1 Biogen1 Danyang Huichuang Medical Equipment Co., Ltd.1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 Talengen Institute of Life Sciences, Shenzhen, P.R. China.1 argenx1 Jiangsu Cancer Institute & Hospital1 Shanghai Mental Health Center1 Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.1 Wangjing Hospital, China Academy of Chinese Medical Sciences1 Southeast University, China1 The Hong Kong Polytechnic University1 Telix Pharmaceuticals (Innovations) Pty Limited1 yifang zhu1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 Sichuan Baili Pharmaceutical Co., Ltd.1 Shanghai Changzheng Hospital1 Dianthus Therapeutics1 First Affiliated Hospital of Guangxi Medical University1 China National Biotec Group Company Limited1 Geneplus-Beijing Co. Ltd.1 Institut de Recherches Internationales Servier (I.R.I.S.)1 Yan Zhang1 ShanShan Li1 Prince of Songkla University1 Bioverativ, a Sanofi company1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Shanghai Juncell Therapeutics1 The University of Hong Kong1 Shanghai Kechow Pharma, Inc.1 Cascade Pharmaceuticals, Inc1 Chengdu New Radiomedicine Technology Co. LTD.1 Xiaoyan Shi1 Bin Gu1 Shanghai Xinzhi BioMed Co., Ltd.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 Oneness Biotech Co., Ltd.1 Boehringer Ingelheim1 Climb Bio, Inc.1 Tongji Hospital1 Shanghai East Hospital1 Shenzhen Core Medical Technology CO.,LTD.1 Anhui Provincial Hospital1 Hangzhou DAC Biotechnology Co., Ltd.1 Nanjing Broad Biopharmaceutical Ltd.1 Zeng Changhao1 Regeneron Pharmaceuticals1 Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.1 Nanjing Medical University1 Shenzhen Kexing Pharmaceutical Co., Ltd.1 Shanghai Ming Ju Biotechnology Co., Ltd.1 yuejun Liu1 Imbioray (Hangzhou) Biomedicine Co., Ltd.1 Boston Scientific Corporation1 Arnatar Therapeutics, Inc.1 Nanjing First Hospital, Nanjing Medical University1 InventisBio Co., Ltd1 Nanfang Hospital, Southern Medical University1 SciClone Pharmaceuticals1 Junbo Ge1 Zenas BioPharma (USA), LLC1 Bivision Pharmaceuticals, Inc.1 Genmab1 Hao Yonggang1 Shanghai Hengrui Pharmaceutical Co., Ltd.1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Shanghai RAAS Blood Products Co., Ltd.1 Duke Kunshan University1 Lei Yunshang Group1 Suzhou Forlong Biotechnology Co., Ltd1
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342 Chengdu1310 Nanjing1213 Changsha1159 Chongqing1081 Fuzhou1043 Tianjin937 Zhengzhou930 Hefei901 Jinan788 Changchun640 Shenzhen582 Harbin549 Nanchang445 Xi'an442 Nanning439 Suzhou427 Shenyang407 Xiamen392 Shijiazhuang348 Lanzhou272 Bengbu218 Wenzhou189 Kunming187 Guiyang182 Qingdao171 Luoyang156 Ningbo152 Taiyuan148 Foshan144 Dalian135 Xuzhou134 Haikou124 Changzhou124 Dongguan106 Shantou101 Nantong99 Hong Kong98 Wuhu92 Wuxi84 Huizhou83 Baoding83 Anyang83 Baotou82 Zhuhai79 Guangdong76 Xi’an71 Liuzhou70 Cangzhou63 Zhongshan60 Hohhot59 Ganzhou57 Xinxiang57 Taizhou55 Yangzhou55 Jiangmen54 Guilin54 Ürümqi52 Guanzhou51 Yiwu50 Zhanjiang48 Zhejiang47 Yinchuan47 Linyi47 Meizhou46 Fuyang46 Nanyang45 Zunyi45 Zhangzhou44 Quanzhou43 Jinhua43 Hanzhou42 Changde42 Lishui42 Huzhou41 Huai'an39 Langfang38 Jining37 Jiaxing37 Fujian36 Tangshan35 Jilin City34 Xiangyang32 Hunan31 Xining31 Henan31 Binzhou30 Daqing30 Kaifeng29 Shandong28 Yantai28 Changzhi28 Chifeng28 Yichang27 Hengyang27 Chengde27 Xingtai26 Sichuan25 Jingzhou25 Xianyang24 Hubei24 Weifang23 Mianyang23 Shiyan23 Wuzhou22 Hebei22 Haerbin21 Luzhou21 Lianyungang21 Wuwei21 Jiamusi20 Shaoguan19 Nanchong19 Deyang19 Bozhou18 Zhenjiang18 Liaocheng18 Anqing18 Chenzhou18 Putian18 Shanxi18 Yancheng18 Shaoxing17 Handan16 Qingyuan16 Quzhou16 Zibo15 Yulin15 Qinhuangdao15 Shangqiu15 Chizhou15 Guangxi14 Xian14 Maoming14 Pingxiang14 Luoyang Shi14 Haidian13 Guizhou13 Heilongjiang13 Zhenzhou12 Xiangtan12 Dongyang12 Jiaozuo12 Shengyang12 Ha’erbin12 Linfen11 Nanjin11 Kunshan11 Chaoyang11 Huaian11 Yan’an11 Ma’anshan11 Suqian11 Beijin11 Guandong11 Huanggang10 Jiujiang10 Qionghai10 Zhuzhou10 Ankang10 Jieyang10 Longyan10 Heyuan10 Tianjing10 Baise City10 Guigang9 Tongling9 Weinan9 Chuzhou9 Hanzhong9 Neijiang9 Liupanshui8 Heze8 Yueyang8 Zigong8 Jiangxi8 Linhai8 Zhaoqing8 Huaihua8 Shaoyang8 Tai’an8 Qinzhou8 Zhoukou8 Dezhou7 Dongying7 Xuchang7 Hengshui7 Shenzhen Shi7 Ch’ang-ch’un7 Zhangjiakou7 Anhui7 Jinjiang7 Sanming7 Fuzhou Fujian7 Hainan7 Cheng Du Shi7 Lu'an7 Yibin7 Sanya7 Dali7 Huainan7 Baoji7 Xicheng7 Kashgar6 Puyang6 Huangshi6 Suining6 Jinzhou6 Meihekou6 Luohe6 Xuancheng6 Chaoyang District6 Zhoushan6 Kaili6 China6 Yuncheng6 Shanghai Shi6 Naning6 Xuhui6 Dazhou6 Macao5 Enshi5 Anshan5 Yuzhong5 Yixing5 Datong5 Yuhuan5 Dongcheng5 Panjin5 Sanmenxia5 Qianjiang5 Shihezi5 Wanzhou5 Changping5 Jiazhuang5 Mudanjiang5 Haidian District5 Tongliao5 Lanxi5 Bijie5 Zhumadian5 Wenling4 Jiangsu4 Weihai4 Xianning4 Taian4 Benxi4 Qinghai4 Huangshan City4 Ya'an4 Ningde4 Hezhou4 Suzhu4 Jiangyin4 Ji'nan4 Qiqihar4 Chaohu4 Pudong4 Changshu4 Jingdezhen4 Yongzhou4 Multiple Locations4 Jiuquan4 Huangpu4 Gaozhou4 Anning4 Chendu4 Yunnan3 Aksu3 Yanan3 Beijingcun3 Shanwei3 Shunde3 Zhujiang3 Changsha Shi3 Rizhao3 Shapingba3 Bishan3 Dongwan3 Anshun3 Minhang District3 Gansu3 Binhai3 Huaibei3 Chongqicun3 Dengzhou3 Yangpu3 Shang'ai3 Loudi3 Leshan3 Ji’an3 Xingyi3 Guankou3 Fushun3 Fuxin3 Guangdong Province3 Hebi3 Yangjiang3 Neimeng3 Jiyuan3 Zhangjiang3 Lhasa3 Weihui3 Beihai3 Xinjiang3 Yunfu3 Linqing2 Maanshan2 Meishan2 Liangyugang2 Ninghai2 Fuling2 Hechuan2 Yichang Shi2 Guiping2 Karamay2 Taipei2 Ningxia2 Xigazê2 Inner Mongolia2 Pingdingshan2 Yichun2 Herbin2 Gongshu District2 Chongqi2 Tongzhou2 Meicheng2 Tongren2 Baotou Shi2 Xuhui District2 Shatin2 Changzhou Shi2 Hechi2 Jishou2 Huayuan2 Dangyang2 Yixingcun2 Dandong2 Zaozhuang2 Yueqing2 Chibi2 Jingjiang2 Suizhou2 Xiaogan2 Jing’an2 Haozhou2 Dingxi2 Changle2 Macau2 Panlong2 Guli2 Many Locations2 Yisa2 Shanhai2 Lincang2 Xicheng District2 Fengtai2 Jincheng2 Rui’an2 Yiyang2 Xinyang2 Danyang2 Qiandongnan Miao and Dong Autonomous Prefecture2 Qiannan2 Jiaxin2 Xiantao2 Tianshui2 Jinzhong2 Guangyuan2 Nan'ning2 Taiwan2 Qujing2 Taihe Chengguanzhen2 Anxi2 Changlexi2 Hetian1 Yangcheng1 Chengdoucun1 Feicheng1 Jingmen1 Chengdu, Sichuan1 Chancheng District1 Liwan District1 North Street1 Nanshan District1 Luoyan1 Hami1 Liu‘an1 Xianmencun1 Zhenngzhou1 Xichengqu Beijing1 Beijing Sheng1 Gunan1 Jiangjin1 Wulong1 Sanhe1 Ruyang1 Qidong1 Xiangya1 Tongji1 Wujin District1 Guangong Apt/Yuncheng1 Chaozhou1 Jimsar1 Luopu1 Yining1 Tainan1 Taoyuan1 Changchuan1 Guangzhusi1 Zhuozhou1 Fyzhou1 Qingyang1 Lingchuan1 Xing’an1 Daming1 Dingxing1 Zhengding1 Wenquan1 Shangluo1 Ji'an1 Dexing1 Wanzai1 Linxia1 Siping1 Wuhai1 Dongguan Shi1 Pinggu1 Xi'an, China1 Chongli1 Beijing, China1 Beijeing1 Deyang Shi1 Foshan Shi1 Taishing1 Xiameng1 Tongchuan1 Hexi District, Tianjin1 Daping1 Pu'er1 Ezhou1 Chengxiang1 Zheng'zhou1 Heihe1 Lianyuan1 Yongji1 Hongcun1 XiAn1 Zhangjiagang1 Nayong1 Yuzhong District1 Shenyany1 Hengzhou1 Duyun1 Ordos1 Chian1 Guanghzou1 Heifei1 Maoming Shi1 Tiyuan1 Nanzhang Chengguanzhen1 Chongzuo1 Laibin1 Pinghu1 Guangxi Zhuang Autonomous Region1 Fulingqu1 Siming1 Changning1 Lingbao1 Fengcheng1 Beijjing1 Zhangye1 Yizheng1 Junxian1 Pingdu1 Zouping1 Huozhou1 Jiexiu1 Hegang1 Shuangyashan1 Suihua1 Louxing District1 Guang’an1 Dongfang1 Minhang1 Shancheng1 Yangzhou SHI1 Cangzhou Shi1 Chongging1 Linquan County1 Guangdong Province Guangzhou City1 Fenyang1 Jiayuguan1 Liangshan1 Ziyang1 Shenzhencun1 Zhaotong1 Yingtan1 Xiangshan1 Liaoyou1 Taihe1 Zhangping1 Longzhou1 Bingjie1 Gannan1 Hexi District1 Jixi1 Yangchun1 Sanjiaocheng1 Chuangchun1 Daozhen Klau and Hmong Autonomous County in Zun'yi1 Qiandongnan Miao and Dong Autonomous Region1 Jina1 Chang’an1 Cili1 Lanshan1 Leiyang1 Pingjiang1 Yangzhong1 Tianmen1 XI 'an City, Shaanxi Province1 Laizhou1 Qinhuangdao Shi1 Linyi Shi1 Linping1 Qingzhen1 Ningxiang1 Jianli City, Jingzhou City1 Jingxi1 Tengzhou Town1 Xiangyang City, Hubei Province1 Changcun1 Chongoing1 Zunhua1 Mengzhou1 Nanle1 Pizhou1 Changshang1 Yanji1 Gu'ang'zhou1 Ulanhot1 Jihan1 Hubei Sheng1 Wenshan Zhuang and Miao Autonomous Prefecture1 Anhui Sheng1 Zhongshan Town1 Yushu1 Sichuan Chengdu1 Jiangse1 Binzhou Shi1 Changhua1 Wuhang1 Gengma County1 Xian City1 Baiyin1 Xinle1 Yunlin1 Bayan Nur1 Anning, Yunnan - South Region1 Beijing, Beijing1 Cangzhou, Hebei - North Region1 Caoxian County, Shandong Province1 Changzhou, Jiangsu Province1 Chengdu, Sichuan Province1 Chongqing, Chongqing1 Chongqing, Sichuan Province1 Wu’an1 Fuding1 Zhuji1 Kaiping1 Heping1 GuiZhou1 HuBei1 HuNan1 Baoshan1 Tanjing1 Haizhu1 Shijia Zhuang1 Jiancheng1 Fuqing1 Nanping1 Tanjin1 Jiading1 Shushan1 Lanfang1 Chuxiong1 Puer1 Wenshan1 Hengshui Shi1 Dazhu1 Dingzhou1 Shang’ai1 Feixian1 Gulin1 Hanyang1 Wannan1 Beiliu1 Guidong1 Xizang1 Gongyi1 Fu'zhou1 Wuha1 Tacheng1 Longgang1 Jinghong1 Zhengjiang1 Puning1 Hongkou1 Heifi1 Changshan1 Najing1 Gui'lin1 Hshijiazhuang1 Wuhou District1 Changshashi1 Shanhu1 Xiangyun1 Xinzheng1 Hangzou1 Yongcheng1 Jining Shi1
All 625 locations
Target enrolment
to

Trials with a site in Suzhou

427 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Chunshui He
Observational
600
Beijing, Xiamen, Hangzhou, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu
2027-01-01
Recruiting
Amgen
Phase 3
180
Hefei, Beijing, Chongqing, Fuzhou, Zhengzhou, Wuhan, Nanjing, Suzhou
2026-12-18
Recruiting
Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care
NCT07372027Hemodialysis Access, Arteriovenous Fistula, Arteriovenous Fistula Cannulation, Vascular Access
Suzhou Municipal Hospital of Anhui Province
Not applicable
100
Suzhou
2026-12-15
Active, closed
Triastek, lnc.
Phase 1
18
Suzhou
2026-11-03
Recruiting
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
20
Changsha, Suzhou
2026-10-31
Not yet open
Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
NCT07902596Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Observational
2,000
Shijiazhuang, Lianyungang, Nanjing, Suzhou, Qingdao, Shanghai
2026-10-25
Recruiting
U69-CART-Cells For R/R T-ALL
NCT07350863Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2026-10-25
Not yet open
Triastek, lnc.
Phase 1
18
Suzhou
2026-10
Not yet open
The Fourth Affiliated Hospital of Soochow University
Not applicable
474
Suzhou, Shanghai
2026-09-30
Not yet open
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1
6
Suzhou
2026-09-28
Not yet open
yifang zhu
Phase 2/3
726
Suzhou
2026-09-20
Recruiting
Boehringer Ingelheim
Phase 3
466
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou
2026-09-17
Recruiting
UCB Biopharma SRL
Phase 3
100
Beijing, Chongqing, Nanchang, Suzhou
2026-09-16
Recruiting
Capital Medical University
Phase 2
204
Anyang, Beijing, Huzhou, Jiuquan, Lishui, Shangqiu, Suzhou, Taizhou
2026-09-06
Recruiting
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma
NCT07760454Relapsed/Refractory Multiple Myeloma
UCARsgen Biotech Limited
Phase 1/2
68
Suzhou, Shanghai
2026-09-03
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
15
Suzhou
2026-09-01
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
204
Guangzhou, Suzhou
2026-09
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
636
Bozhou, Hefei, Suzhou, Beijing, Fuzhou, Lanzhou, Qingyang, Dongguan
2026-08-21
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2
39
Suzhou
2026-08-20
Recruiting
DEC003M in Prostate Cancer
NCT07657806Advanced Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Beijing, Suzhou, Chengdu, Hangzhou, Wenzhou, Chongqing
2026-08-19
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
356
Chongqing, Nanning, Guangzhou, Hohhot, Suzhou, Nanchang, Hangzhou, Taiyuan
2026-08-19
Recruiting
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08-14
Recruiting
Probiotics Improve Constipation
NCT07765004Constipation
Wecare Probiotics Co., Ltd.
Not applicable
76
Suzhou
2026-08-07
Not yet open
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Recruiting
Beijing Tiantan Hospital
Observational
3,000
Beijing, Zhengzhou, Wuhan, Suzhou, Nanchang, Shanghai, Chengdu, Hangzhou
2026-08-03
Not yet open
Cousin vs. Sibling Donors in Haplo-HSCT
NCT07662382Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor
The First Affiliated Hospital of Soochow University
Observational
1,000
Suzhou
2026-08-01
Not yet open
Safety and Feasibility of FMT for Immune Recovery After HSCT
NCT07755319Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 1/2
86
Suzhou
2026-08-01
Not yet open
Children's Hospital of Soochow University
Not applicable
30
Suzhou
2026-08
Not yet open
A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients
NCT07762508Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2026-08
Not yet open
U96-CAR-T-Cells For R/R B-ALL
NCT07511426Relapsed or Refractory B Cell Leukemia and Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
30
Suzhou
2026-07-30
Recruiting
Adults With Constipation
NCT07529457Constipation
Wecare Probiotics Co., Ltd.
Not applicable
70
Suzhou
2026-07-24
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2
96
Suzhou
2026-07-22
Recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
62
Suzhou
2026-07-15
Not yet open
Younger vs. Older Donors in Allo-HSCT: TTE
NCT07666568A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
Observational
5,000
Suzhou
2026-07-15
Recruiting
Angitia Biopharmaceuticals Guangzhou Limited
Phase 2
48
Beijing, Shenzhen, Changsha, Suzhou, Shanghai
2026-07-14
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Recruiting
Huashan Hospital
Phase 2
90
Fuzhou, Guangzhou, Guiyang, Liupanshui, Zunyi, Suzhou, Ganzhou, Xining
2026-07-08
Recruiting
ShanShan Li
Observational
300
Shenzhen, Huai'an, Suzhou, Xuzhou, Dongying, Shanghai, Changzhou, Jiaozuo
2026-07-02
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 4
20
Suzhou
2026-07-01
Recruiting
Climb Bio, Inc.
Phase 1/2
30
Mianyang, Baoji, Beijing, Bengbu, Changsha, Hefei, Nanchang, Suzhou
2026-06-30
Recruiting
BeOne Medicines
Phase 1
118
Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin
2026-06-23
Not yet open
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
NCT07606937Relapsed/Refractory Large B-cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Early Phase 1
12
Beijing, Guangzhou, Suzhou, Shanghai, Chengdu, Tianjin
2026-06-12
Recruiting
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Not yet open
Probiotics for Constipation Relief in Adults
NCT07507955Functional Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Recruiting
Probiotic Improve Constipation
NCT07462481Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Recruiting
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Phase 1/2
60
Suzhou
2026-06-04
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Chengdu, Beijing, Jinan, Shanghai, Suzhou, Wuhan
2026-06-03
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1
99
Suzhou
2026-06-02
Recruiting
VA Consolidation in Intermediate-Risk AML
NCT07672262Acute Myeloid Leukemia, Intermediate Risk Acute Myeloid Leukemia, Consolidation Therapy
The First Affiliated Hospital of Soochow University
Phase 2
226
Suzhou
2026-06-01
Recruiting
CMV-CMI in csCMVi After HSCT
NCT07688759Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation (HSCT), Immune Reconstitution
The First Affiliated Hospital of Soochow University
Observational
40
Suzhou
2026-06-01
Not yet open
The Hong Kong Polytechnic University
Not applicable
54
Kunshan, Suzhou, Suzhu
2026-06-01
Recruiting
Second Affiliated Hospital of Soochow University
Early Phase 1
30
Suzhou
2026-06-01
By invitation
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing, Suzhou
2026-06-01
Recruiting
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2026-06-01
Not yet open
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
NCT07635485Hypoplastic Acute Myeloid Leukemia, Secondary AML (Adult)
The First Affiliated Hospital of Soochow University
Not applicable
50
Suzhou
2026-06-01
Not yet open
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
180
Suzhou
2026-06
Not yet open
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
160
Suzhou
2026-06
Recruiting
UCB Biopharma SRL
Phase 3
120
Beijing, Chengdu, Chongqing, Nanchang, Suzhou
2026-05-27
Active, closed
The First Affiliated Hospital of Soochow University
Early Phase 1
12
Suzhou
2026-05-20
Active, closed
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
VABu Conditioning in Elderly AML HSCT
NCT07583888Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 2/3
20
Suzhou
2026-05-07
Recruiting
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Not yet open
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma
The First Affiliated Hospital of Soochow University
Observational
30
Suzhou
2026-05-01
Recruiting
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2026-05-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2
52
Suzhou
2026-05-01
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Recruiting
Sinomune Pharmaceutical Co., Ltd
Phase 1
48
Suzhou
2026-04-24
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
Capital Medical University
Phase 3
348
Huaibei, Suzhou, Heyuan, Maoming, Qinhuangdao, Tangshan, Anyang, Hebi
2026-04-22
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xi’an, Hangzhou
2026-04-16
Recruiting
magAssist, Inc.
Not applicable
204
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Shenyang, Suzhou, Xi'an
2026-04-09
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Baotou, Nanjing, Suzhou, Changchun
2026-04-01
Recruiting
Effect of VR-MBCT in Chronic Nonspecific Low Back Pain
NCT07589790Chronic Non-specific Low Back Pain
The First Affiliated Hospital of Soochow University
Not applicable
214
Suzhou
2026-04-01
Recruiting
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NCT07500753Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2026-04-01
Recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
24
Suzhou
2026-03-30
Recruiting
Zhangjiagang First People's Hospital
Phase 4
520
Suzhou
2026-03-29
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 1
3
Suzhou
2026-03-27
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
124
Suzhou
2026-03-24
Recruiting
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
15
Beijing, Suzhou, Jinan, Tianjin, Hangzhou
2026-03-17
Recruiting
Romiplostim for Oral TPO-RA Resistant ITP
NCT07612319Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University
Not applicable
60
Suzhou
2026-03-15
Recruiting
BY002 IIT Study in R/R Acute Leukemia
NCT07270770Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
DrugBY002
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2026-03-15
Recruiting
Phase II Trial of RC1416 Injection in Asthma
NCT07403487Moderate to Severe Asthma
DrugRC1416
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
195
Anqing, Suzhou, Beijing, Chongqing, Lanzhou, Shijiazhuang, Tangshan, Xingtai
2026-03-10
Active, closed
Mass Balance Study of [14C] D-2570
NCT07411742Mass Balance Study
InventisBio Co., Ltd
Phase 1
8
Suzhou
2026-03-10
Recruiting
Phase II Study of RC1416 Injection in COPD
NCT07402551Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
DrugRC1416
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
180
Hefei, Suzhou, Chongqing, Xiamen, Guangzhou, Huizhou, Jiangmen, Qingyuan
2026-03-06
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Recruiting
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
NCT07425782Acute Myeloid Leukemia, Consolidation Therapy, Venentoclax, High Risk
The First Affiliated Hospital of Soochow University
Phase 2
216
Suzhou
2026-02-01
Not yet open
Zeng Changhao
Not applicable
474
Suzhou, Zhenzhou
2026-02
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
66
Suzhou
2026-01-31
Not yet open
China National Biotec Group Company Limited
Observational
600
Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang
2026-01-30
Recruiting
Shanghai Mental Health Center
Observational
121
Suzhou, Xuzhou, Shanghai, Hangzhou, Ningbo
2026-01-24
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2026-01-15
Recruiting
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Zhengzhou, Suzhou, Changchun, Dalian, Xi'an
2026-01-15
Not yet open
Osteoporotic Vertebral Compression Fracture Cohort Study
NCT07321795OVCF Database, Cohort Study
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Hunan, Suzhou, Weihai, Beijing
2026-01-10
Active, closed
The Children's Hospital of Zhejiang University School of Medicine
Observational
300
Hefei, Suzhou, Kunming, Hangzhou, Wenling
2026-01-01
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
25
Suzhou
2026-01-01
Active, closed
Efficacy of Vitamin D in Post-Stroke Cognitive Impairment
NCT07767214Post-Stroke Cognitive Impairment (PSCI)
Suzhou Municipal Hospital of Anhui Province
Not applicable
300
Suzhou
2026-01-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
35
Suzhou
2026-01-01
Recruiting
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 1
30
Suzhou
2026-01-01
Recruiting
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 1
30
Suzhou
2026-01
Not yet open
Second Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2025-12-27
Recruiting
Capital Medical University
Phase 3
1,192
Anqing, Bozhou, Fuyang, Ma’anshan, Suzhou, Wuhu, Beijing, Fuzhou
2025-12-18
Active, closed
Capital Medical University
Not applicable
208
Fuyang, Suzhou, Beijing, Zhoukou, Shihezi
2025-12-18
Not yet open
Zhao Jun
Observational
200
Suzhou
2025-12-17
Not yet open
Second Affiliated Hospital of Soochow University
Phase 3
312
Suzhou
2025-12-15
Recruiting
Lei Yunshang Group
Phase 1
120
Suzhou
2025-12-15
Recruiting
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early Phase 1
15
Suzhou
2025-12-12
Recruiting
Changhai Hospital
Not applicable
376
Chongqing, Guangzhou, Shenzhen, Kaifeng, Zhengzhou, Changsha, Suzhou, Nanchang
2025-12-10
Recruiting
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-10
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
42
Chongqing, Guangzhou, Chengde, Tangshan, Nanjing, Suzhou, Nanchang, Xi'an
2025-12-09
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
64
Suzhou
2025-12-08
Active, closed
Capital Medical University
Phase 3
692
Suzhou, Zhangzhou, Qinzhou, Langfang, Qinhuangdao, Tangshan, Harbin, Anyang
2025-12-05
Recruiting
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
NCT07284927Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
DrugLV009
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1
10
Suzhou
2025-12-03
Recruiting
Sanofi
Phase 2
37
Beijing, Shanghai, Shenzhen, Suzhou
2025-12-02
Recruiting
PRaG-1 Plus PRaG Therapy in in Elderly Patients With Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)
NCT07267234Solid Cancer, Lymphopenia, Radiotherapy, Immune Checkpoint Inhibitor
Second Affiliated Hospital of Soochow University
Phase 2
65
Suzhou
2025-12-01
Recruiting
Second Affiliated Hospital of Soochow University
Phase 2
127
Suzhou
2025-12-01
Not yet open
Shanghai Changzheng Hospital
Observational
1,100
Beijing, Guangzhou, Nanjing, Suzhou, Shanghai, Chengdu, Ningbo
2025-12
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2025-11-30
Recruiting
Shanghai RAAS Blood Products Co., Ltd.
Phase 2
24
Changsha, Hefei, Jinan, Nanning, Suzhou, Taiyuan, Tangshan, Tianjin
2025-11-26
Recruiting
IVIEW Therapeutics Inc.
Phase 1/2
6
Suzhou
2025-11-19
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
NCT07805967Multiple System Atrophy, Dementia With Lewy Bodies (DLB), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Second Affiliated Hospital of Soochow University
Observational
500
Changshu, Huai'an, Kunshan, Nanjing, Nantong, Suqian, Suzhou, Xuzhou
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Guangzhou, Zunyi, Zhengzhou, Wuhan, Hohhot, Suzhou, Changchun, Shenyang
2025-11-11
Recruiting
Ascentage Pharma Group Inc.
Phase 1
48
Suzhou
2025-11-11
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2025-11-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 4
40
Suzhou
2025-11-01
Recruiting
Hao Yonggang
Not applicable
910
Suzhou
2025-11-01
Recruiting
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
12
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Active, closed
A Phase Ⅰ b Clinical Study of ART101 Injection
NCT07614308Hypertension (HTN)
Arnatar Therapeutics, Inc.
Phase 1
16
Suzhou
2025-10-27
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NCT07208097Intracerebral Haemorrhage, Minimally Invasive Treatment
Tongji Hospital
Not applicable
768
Anqing, Hefei, Suzhou, Guangzhou, Nanning, Bijie, Guiyang, Kaili
2025-10-25
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
23
Suzhou
2025-10-24
Recruiting
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
NCT07095075Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Early Phase 1
36
Bengbu, Hefei, Nanjing, Suzhou, Wenzhou
2025-10-14
Recruiting
Children's Hospital of Soochow University
Observational
150
Suzhou
2025-10-13
Recruiting
Takeda
Phase 3
20
Beijing, Guangzhou, Jihan, Shanghai, Suzhou, Tianjin, Wuhan
2025-10-13
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
224
Suzhou, Xuzhou, Hangzhou
2025-10-01
Active, closed
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Recruiting
Children's Hospital of Soochow University
Not applicable
1,380
Suzhou
2025-09-26
Recruiting
PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
NCT07188610CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 2
100
Hefei, Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou
2025-09-25
Recruiting
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
NCT07172204Intensive Chemotherapy Unfit, Newly Diagnosed Acute Myeloid Leukemia (AML), Age ≥60
First Affiliated Hospital of Zhejiang University
Phase 2
25
Beijing, Shenzhen, Suzhou, Nanchang, Hangzhou
2025-09-16
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Fuzhou, Guangzhou, Beijing, Guanzhou, Suzhou, Xi'an
2025-09-16
Recruiting
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML
NCT07451912Acute Myeloid Leukemia (AML), CEBPA Mutation, Unfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University
Phase 1/2
29
Suzhou
2025-09-15
Recruiting
The University of Hong Kong
Not applicable
232
Suzhou
2025-09-08
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
27
Suzhou
2025-09-01
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2025-09-01
Recruiting
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NCT07068438Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
210
Hefei, Beijing, Changzhou, Suzhou, Wuxi, Xuzhou, Nanchang, Hangzhou
2025-09-01
Not yet open
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
NCT07126288Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 2/3
268
Xiamen, Nanyang, Xinxiang, Wuhan, Suzhou, Nanchang, Pingxiang, Changchun
2025-08-31
Recruiting
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Recruiting
Sanofi
Phase 3
90
Beijing, Chengde, Guangzhou, Hohhot, Nanchang, Suzhou, Tianjin, Wuhan
2025-08-18
Recruiting
Takeda
Phase 3
150
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-08-14
Recruiting
Interventional Left Ventricular Assist System for PCI in CHIP Patients
NCT07053618High-Risk Percutaneous Coronary Intervention (High-risk PCI), Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
286
Beijing, Xiamen, Lanzhou, Guangzhou, Zhengzhou, Changsha, Suzhou, Nanchang
2025-08-06
Recruiting
Probiotics and Non-Organic Gastrointestinal Improvement
NCT07081100Gastrointestinal Function
Wecare Probiotics Co., Ltd.
Not applicable
50
Suzhou
2025-08-05
Recruiting
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, Acute Leukemia
DrugBN104
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2025-08-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2025-07-30
Recruiting
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
NCT06730256Relapsed/Refractory Plasma Cell Leukemia, Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University
Early Phase 1
24
Suzhou
2025-07-23
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-14
Active, closed
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-07-10
Not yet open
Prince of Songkla University
Not applicable
90
Suzhou
2025-07-09
Recruiting
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
NCT07072247Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-07
Active, closed
Sanofi
Phase 2
105
Huizhou, Guangzhou, Nanjing, Suzhou, Wuxi, Shanghai, Hangzhou, Ningbo
2025-07-07
Recruiting
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1/2
20
Suzhou
2025-07-03
By invitation
The First Affiliated Hospital of Soochow University
Not applicable
10
Suzhou
2025-07-03
By invitation
Junbo Ge
Not applicable
40
Hefei, Suzhou, Shanghai
2025-07-01
Active, closed
Duke Kunshan University
Not applicable
600
Suzhou
2025-06-20
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2025-06-20
Recruiting
Du Zhenggui
Not applicable
337
Fuzhou, Guangzhou, Anyang, Zhengzhou, Changsha, Hohhot, Suzhou, Nanchang
2025-06-17
Recruiting
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
NCT07007949Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib
The First Affiliated Hospital of Soochow University
Phase 2
42
Suzhou
2025-06-01
Recruiting
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
NCT07047573Lung Cancer (Diagnosis), Pulmonary Nodule Persistent
Zhao Jun
Observational
150
Suzhou
2025-06-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2/3
30
Suzhou
2025-06-01
Recruiting
Anhui Provincial Hospital
Observational
600
Hefei, Suzhou, Ningbo
2025-06-01
Not yet open
Starna Therapeutics
Early Phase 1
30
Suzhou
2025-06
Recruiting
GeneCradle Inc
Phase 3
50
Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
2025-05-27
Recruiting
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
NCT07562542Systemic Mastocytosis, KIT-D816V Mutation
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-05-19
Not yet open
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06970951Systemic Lupus Erythematosus, Rheumatoid Arthritis, Dry Syndrome, Idiopathic Inflammatory Myopathies
DrugUTAA91
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early Phase 1
15
Suzhou
2025-05-18
Recruiting
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
NCT06985485Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab, Inotuzumab Ozogamicin
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2025-05-17
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
NCT07028073Acute Myeloid Leukemia With T(8;21)(Q22;Q22), Acute Myeloid Leukemia With T(16;16)(P13;Q22), KIT Gene Mutation, Avapritinib
The First Affiliated Hospital of Soochow University
Phase 1/2
78
Suzhou
2025-05-15
Active, closed
Wellizen Australia
Phase 2
16
Suzhou
2025-05-09
Recruiting
The First Affiliated Hospital of Soochow University
Observational
300
Suzhou
2025-05-01
Recruiting
Shanghai East Hospital
Phase 3
2,423
Suzhou, Shanghai
2025-04-30
Recruiting
Dapagliflozin in Allo-HCT for aGVHD
NCT06626737Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University
Phase 2
72
Suzhou
2025-04-26
Recruiting
Wecare Probiotics Co., Ltd.
Not applicable
80
Suzhou
2025-04-10
Not yet open
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
NCT06838520Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Changzhou, Nanjing, Suzhou, Yangzhou
2025-04-01
Recruiting
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
NCT07564453B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University
Phase 2
101
Suzhou
2025-04-01
Recruiting
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
NCT07012447Early T Acute Lymphoblastic Leukemia, T-Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T/Myeloid, Nos
yuejun Liu
Phase 2
32
Suzhou
2025-04-01
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
110
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
240
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Recruiting
Soochow University
Observational
400
Suzhou
2025-03-31
Active, closed
Soochow University
Not applicable
1,486
Suzhou
2025-03-24
Recruiting
Zhangjiagang First People's Hospital
Not applicable
552
Suzhou
2025-03-24
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
40
Suzhou
2025-03-18
Active, closed
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
NCT06686485Concomitant Procedures, Atrial Fibrillation, PFA, LAAC
Boston Scientific Corporation
Observational
433
Suzhou, Beijing, Chengdu, Guangzhou, Guiyang, Hangzhou, Jinan, Kunming
2025-03-18
Recruiting
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Recruiting
Investigation of Tetralogy of Fallot in Neonates
NCT06822400Tetralogy of Fallot (TOF), Pulmonary Stenosis, Ventricular Septal Defects (VSD), Double Outlet Right Ventricle
Beijing Anzhen Hospital
Not applicable
160
Beijing, Chengdu, Shanghai, Shenzhen, Suzhou
2025-03-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xi’an
2025-03-01
Not yet open
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
NCT06849011Stroke Acute, Encephalitis, Non-traumatic Brain Injury
Yan Zhang
Observational
1,185
Beijing, Lanzhou, Guiyang, Zunyi, Tangshan, Shijiazhuang, Hohhot, Suzhou
2025-03-01
Not yet open
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Recruiting
Children's Hospital of Soochow University
Not applicable
90
Wuhan, Suzhou, Changchun
2025-03
Recruiting
Shanghai Kechow Pharma, Inc.
Phase 1
52
Suzhou
2025-02-28
Recruiting
Takeda
Phase 3
171
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-02-27
By invitation
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 1
78
Suzhou
2025-02-26
Recruiting
Wecare Probiotics Co., Ltd.
Not applicable
84
Suzhou
2025-02-25
Not yet open
The First Affiliated Hospital of Soochow University
Not applicable
158
Suzhou
2025-02-15
Active, closed
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Hefei, Guangzhou, Changsha, Chifeng, Suzhou, Beijing, Chengdu, Fujian
2025-02-10
Recruiting
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
NCT06797284Insomnia Chronic, Narcolepsy, REM Sleep Behavior Disorder
Second Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2025-02-01
Recruiting
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
NCT06816134Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell, Conditioning Therapy
The First Affiliated Hospital of Soochow University
Phase 2
48
Suzhou
2025-01-30
Recruiting
BeOne Medicines
Phase 1/2
258
Beijing, Guangzhou, Suzhou
2025-01-23
Not yet open
Second Affiliated Hospital of Soochow University
Not applicable
200
Suzhou
2025-01-18
Recruiting
First Affiliated Hospital of Guangxi Medical University
Observational
500
Nanning, Qinzhou, Wuzhou, Yulin, Suzhou
2025-01-06
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2025-01-02
By invitation
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
NCT07176091Parkinsonism, Transcranial Magnetic Stimilation, Intermittent Theta Burst Stimulation, Primary Motor Cortex
Second Affiliated Hospital of Soochow University
Not applicable
90
Suzhou
2025-01-01
Recruiting
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
NCT06754488Posterior Bladder Wall Reconstruction, Anterior Bladder Wall Reconstruction, Anterior Bladder Wall Suspension
Suzhou Municipal Hospital
Not applicable
120
Suzhou
2025-01-01
Recruiting
Chen Suning
Phase 1/2
135
Suzhou
2024-12-25
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Hefei, Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-12-18
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
330
Suzhou
2024-12-16
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2024-12-10
Not yet open
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
NCT06673459T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
The First Affiliated Hospital of Soochow University
Phase 3
430
Suzhou
2024-12-01
Recruiting
Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
NCT07581756Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Chronic Diarrhea
The First Affiliated Hospital of Soochow University
Not applicable
46
Suzhou
2024-12-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
400
Suzhou
2024-12-01
Recruiting
The First Affiliated Hospital of Soochow University
Early Phase 1
18
Suzhou
2024-12-01
Not yet open
Geneplus-Beijing Co. Ltd.
Observational
80
Suzhou
2024-12-01
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-12-01
Not yet open
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
10
Suzhou
2024-12
Recruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
NCT06682416Epidural Related Maternal Fever, Analgesia, Epidural, Fever, Intrapartum Fever
The First Affiliated Hospital of Soochow University
Not applicable
424
Suzhou
2024-11-30
Recruiting
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Active, closed
Pfizer
Phase 3
636
Beijing, Chongqing, Guangzhou, Jingzhou, Wuhan, Changsha, Suzhou, Wuxi
2024-11-15
Recruiting
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
NCT06682130Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-11-10
Recruiting
Capital Medical University
Phase 3
1,184
Bengbu, Bozhou, Huaibei, Suzhou, Beijing, Haidian, Pinggu, Tongzhou
2024-11-07
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
43
Suzhou
2024-11-01
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-11-01
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
47
Suzhou
2024-11-01
Active, closed
Capital Medical University
Phase 3
1,300
Fuyang, Huainan, Suzhou, Wuhu, Beijing, Chongqing, Zhangzhou, Foshan
2024-10-10
Recruiting
Xiaoyan Shi
Not applicable
128
Suzhou
2024-09-28
Recruiting
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)
NCT06559241Acute Ischemic Stroke, Anterior Circulation Brain Infarction
Capital Medical University
Phase 3
2,105
Suzhou, Taihe Chengguanzhen, Tongling, Beijing, Fuzhou, Zhangzhou, Heyuan, Huizhou
2024-09-23
Recruiting
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
33
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
2024-09-19
Recruiting
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2024-09-10
Recruiting
Shanghai Jiatan Pharmatech Co., Ltd
Phase 1
10
Suzhou
2024-09-04
Not yet open
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
NCT06559644Leukemia, Myeloid, Acute, B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Early Phase 1
20
Suzhou
2024-09-01
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
93
Beijing, Suzhou, Tianjin, Ürümqi, Wuhan
2024-08-26
Active, closed
Oneness Biotech Co., Ltd.
Phase 2/3
120
Jiangmen, Luoyang, Suzhou, Zhenjiang, Shenyang, Xi'an, Hangzhou, Guangzhou
2024-08-16
Recruiting
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Recruiting
A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects
NCT06599528Assisted Reproductive Technology, Female Infertility
Suzhou Centergene Pharmaceuticals Co.,Ltd.
Phase 1
48
Suzhou
2024-08-12
Recruiting
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
NCT06615193Advanced Solid Tumors, Refractory Lymphoma, Relapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
111
Zhengzhou, Suzhou, Xuzhou, Nanchang, Jinan, Hangzhou, Tianjing
2024-08-12
Recruiting
SciClone Pharmaceuticals
Observational
450
Suzhou
2024-08-08
Active, closed
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031Crohn Disease, Stricture; Bowel, Intestinal Stricture
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
239
Beijing, Chongqing, Guangzhou, Huai'an, Suzhou, Yangzhou, Hangzhou
2024-08-01
Recruiting
Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea
NCT06757491Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, Functional Magnetic Resonance Imaging, IBS (Irritable Bowel Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2024-08-01
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Hefei, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Xi'an, Xianyang
2024-07-31
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
172
Suzhou
2024-07-29
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Active, closed
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
NCT06054113B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
Amgen
Phase 2
18
Hefei, Chongqing, Guangzhou, Wuhan, Suzhou, Shanghai, Tianjin
2024-07-23
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-07-10
Active, closed
Tianjin Medical University General Hospital
Phase 2/3
102
Hefei, Lanzhou, Shijiazhuang, Harbin, Zhenzhou, Ordos, Changzhou, Suzhou
2024-07-09
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
197
Suzhou
2024-07-08
Active, closed
SIM0718 Treatment of Asthma Clinical Study
NCT06488755Asthma; Eosinophilic
Simcere Pharmaceutical Co., Ltd
Phase 3
418
Hefei, Suzhou, Beijing, Chongqing, Lanzhou, Foshan, Guangzhou, Huizhou
2024-06-23
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 3
360
Beijing, Guangzhou, Luoyang, Zhengzhou, Wuhan, Suzhou, Taiyuan, Xi’an
2024-06-14
Recruiting
The First Affiliated Hospital of Soochow University
Phase 4
59
Suzhou
2024-06-12
Recruiting
A Study of GLB-001 in Patients With Myeloid Malignancies
NCT06378437Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes
Hangzhou GluBio Pharmaceutical Co., Ltd.
Phase 1
108
Hefei, Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-05-24
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Guangzhou, Shantou, Nanjing, Suzhou, Nanchang, Pingxiang, Changchun, Linyi
2024-05-21
Active, closed
AbbVie
Phase 3
421
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang
2024-05-19
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2/3
44
Suzhou
2024-05-01
Not yet open
Changhai Hospital
Not applicable
200
Guangzhou, Suzhou, Wuxi, Ningbo, Shanghai
2024-05-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
30
Suzhou
2024-04-25
Active, closed
Amgen
Phase 3
111
Beijing, Shenzhen, Wuhan, Suzhou, Changchun, Jinan, Chengdu, Shanghai
2024-04-22
Recruiting
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4
100
Beijing, Suzhou, Jinan, Jining, Taiyuan
2024-04-07
Recruiting
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
NCT06381817Acute T Cell Lymphoblastic Leukemia, Haploidentical Hematopoietic Stem Cell Transplantation, Cord Blood
The First Affiliated Hospital of Soochow University
Phase 3
146
Suzhou
2024-04-01
Recruiting
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06279026Relapsed/Refractory Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Not applicable
15
Suzhou
2024-04-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1
4
Suzhou
2024-04-01
Recruiting
VA vs DA for Newly Diagnosed Hig-risk AML
NCT05939180Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
116
Suzhou
2024-04-01
Recruiting
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 1
18
Suzhou
2024-03-26
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
80
Zhengzhou, Nanjing, Suzhou, Shanghai, Wenzhou
2024-03-19
Recruiting
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Active, closed
Nanjing Medical University
Not applicable
934
Suzhou
2024-03-08
Recruiting
Takeda
Phase 2
268
Chongqing, Xiamen, Guangzhou, Huizhou, Wuhan, Changsha, Changzhou, Suzhou
2024-03-05
Recruiting
Suzhou Municipal Hospital
Not applicable
30
Nanjing, Nantong, Suzhou
2024-03-01
Recruiting
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
NCT06316960AML, Childhood, Relapse/Recurrence, Refractory AML, Core Binding Factor Acute Myeloid Leukemia
Children's Hospital of Soochow University
Phase 2
50
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-03-01
Recruiting
Suzhou Municipal Hospital
Not applicable
300
Suzhou
2024-02-26
Not yet open
Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
NCT06289959Lymphoma, Large B-Cell, Diffuse
Second Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2024-02-25
Recruiting
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
NCT06394011Intermediate Risk Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2024-02-15
Recruiting
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
NCT06250959ALL, Adult, Philadelphia-Negative ALL
Chen Suning
Phase 2
124
Suzhou
2024-02-05
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
32
Suzhou
2024-02-01
Recruiting
Second Affiliated Hospital of Soochow University
Not applicable
34
Suzhou
2024-02-01
Recruiting
Myasthenia Gravis Registry in China
NCT06241521Myasthenia Gravis
Huashan Hospital
Observational
1,500
Beijing, Chongqing, Guangzhou, Zhengzhou, Changsha, Suzhou, Xuzhou, Nanchang
2024-02-01
Recruiting
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
58
Zhengzhou, Suzhou, Shanghai, Chongqing, Tianjin
2024-01-09
Recruiting
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College
Not applicable
272
Fuyang, Hefei, Huainan, Huangshan City, Suzhou, Wuhu, Xiangyang
2024-01-04
Recruiting
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
55
Beijing, Guangzhou, Guiyang, Wuhan, Changsha, Suzhou, Xi’an, Chengde
2024-01-03
Recruiting
The First Affiliated Hospital of Soochow University
Early Phase 1
20
Suzhou
2024-01-01
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-01-01
Recruiting
Children's Hospital of Soochow University
Phase 2
500
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-01-01
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Beijing, Guangzhou, Zhengzhou, Suzhou, Nanchang, Shenyang, Qingdao, Shanghai
2023-12-29
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca
Phase 1/2
255
Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Suzhou, Tianjin, Zhengzhou
2023-12-29
Recruiting
Bivision Pharmaceuticals, Inc.
Phase 1/2
90
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Wuxi
2023-12-22
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xi’an, Chengdu
2023-12-01
Recruiting
Southeast University, China
Not applicable
404
Hefei, Jinjiang, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Taizhou
2023-11-27
Recruiting
Second Affiliated Hospital of Soochow University
Observational
300
Suzhou
2023-11-17
Recruiting
Second Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2023-11-07
Active, closed
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
NCT06093841Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma, Mediastinal B-Cell Diffuse Large Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 2
46
Guangzhou, Zhengzhou, Changsha, Suzhou, Jinan, Shanghai, Tianjin, Hangzhou
2023-11-03
Active, closed
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2
13
Suzhou
2023-10-29
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 3
222
Fuzhou, Xiamen, Nanning, Nanjin, Suzhou, Shanghai, Kunming
2023-10-19
Active, closed
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813ALL, Adult, AML, Adult, Acute Leukaemia, KMT2A Rearrangement
DrugBN104
Institut de Recherches Internationales Servier (I.R.I.S.)
Phase 1/2
66
Suzhou
2023-10-19
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
408
Beijing, Lanzhou, Shijiazhuang, Luoyang, Wuhan, Suzhou, Nanchong, Tianjin
2023-09-11
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc.
Phase 3
350
Bengbu, Chongqing, Guangdong, Zhengzhou, Wuhan, Suzhou, Shanghai, Chengdu
2023-08-31
By invitation
The First Affiliated Hospital of Soochow University
Phase 2/3
98
Suzhou
2023-08-01
Recruiting
Venetoclax Combined With Azactidine in the Treatment of ALAL
NCT05901974Acute Leukemia of Ambiguous Lineage
Sheng-Li Xue, MD
Phase 2
23
Suzhou
2023-07-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 2
22
Suzhou
2023-07-01
By invitation
The First Affiliated Hospital of Soochow University
Phase 2
20
Suzhou
2023-07-01
Recruiting
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2
25
Suzhou
2023-06-01
By invitation
Abbisko Therapeutics Co, Ltd
Phase 2
64
Beijing, Chongqing, Fuzhou, Guangzhou, Zhujiang, Wuhan, Hangzhou, Suzhou
2023-05-30
Recruiting
Statins for Treatment of Primary Intracerebral Hemorrhage
NCT07088250Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral Haemorrhage
The Second Hospital of Anhui Medical University
Not applicable
264
Anqing, Fuyang, Hefei, Huainan, Lu'an, Suzhou, Harbin, Kaifeng
2023-05-06
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
Institut de Recherches Internationales Servier
Phase 1/2
554
Beijing, Jinan, Shanghai, Suzhou
2023-04-18
Recruiting
Nanfang Hospital, Southern Medical University
Phase 4
7,188
Hefei, Huainan, Suzhou, Beijing, Chongqing, Foshan, Guangzhou, Zhongshan
2023-04-03
Recruiting
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05768529Relapsed or Refractory Non-Hodgkin's Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1/2
100
Changsha, Suzhou, Shanghai
2023-03-28
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
43
Suzhou
2023-03-15
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Guangzhou, Shantou, Haikou, Zhuzhou, Nanjing, Suzhou, Nanchang, Pingxiang
2023-03-02
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2/3
60
Suzhou
2023-03-01
By invitation
FMT in Transplant-related Gastrointestinal Mucositis
NCT07622849Transplant-related Gastrointestinal Mucositis
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2023-03-01
Recruiting
GeneCradle Inc
Phase 1/2
18
Beijing, Shenyang, Suzhou
2023-02-25
Recruiting
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
NCT05641259Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
198
Nanchang, Suzhou, Zhengzhou
2023-02-14
Recruiting
Zhao Jun
Observational
50
Suzhou
2023-02-12
Active, closed
AstraZeneca
Phase 2
51
Beijing, Chengdu, Fuzhou, Guangzhou, Kunming, Ningbo, Shijiazhuang, Suzhou
2023-02-09
Recruiting
Suzhou Municipal Hospital
Phase 2
32
Suzhou
2023-01-16
Active, closed
Adult Spinal Muscular Atrophy (SMA) China Registry
NCT05618379Muscular Atrophy, Spinal
Biogen
Observational
200
Beijing, Fuzhou, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Nanchang
2023-01-06
Active, closed
Janssen Research & Development, LLC
Phase 3
214
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Suzhou
2022-12-15
Recruiting
Construction of a Database for TMA
NCT05634928Thrombotic Microangiopathies
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-12-01
Recruiting
Xuanwu Hospital, Beijing
Observational
16,000
Beijing, Changchun, Chengdu, Suzhou
2022-12-01
Recruiting
Huashan Hospital
Observational
1,255
Lanzhou, Harbin, Hohhot, Suzhou, Xuzhou, Shenyang, Jinan, Jining
2022-12-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
4,500
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2022-12
Recruiting
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
120
Suzhou
2022-11-24
Recruiting
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
NCT05349955Type 2 Diabetes, Cardiovascular Complication, Diabetic Kidney Disease
Shanghai Zhongshan Hospital
Not applicable
5,600
Suzhou
2022-11-21
Recruiting
Construction of a Database for TTP
NCT05571774TTP - Thrombotic Thrombocytopenic Purpura
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-10-20
Active, closed
Healthguard Biomed
Not applicable
207
Suzhou
2022-10-19
Recruiting
CAV Regimen for R/R AML
NCT05657639Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
68
Suzhou
2022-10-01
Recruiting
CAV Regimen for R/R Ph- B-ALL
NCT05657652Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
36
Suzhou
2022-10-01
Active, closed
GlaxoSmithKline
Phase 3
110
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Suzhou, Wuhan
2022-09-06
Recruiting
Olverembatinib for FGFR1-rearranged Neoplasms
NCT05521204Myeloproliferative Neoplasm, Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
20
Suzhou
2022-09-01
Recruiting
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
NCT05940961ALL, MRD-positive, Hematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD
Phase 2
42
Suzhou
2022-08-01
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC
Phase 2
189
Beijing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Xuzhou, Nanchang, Chuangchun
2022-07-21
Active, closed
Novartis Pharmaceuticals
Phase 4
134
Chongqing, Shijiazhuang, Harbin, Changsha, Nanjing, Suzhou, Changchun, Kunming
2022-07-07
Recruiting
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
110
Suzhou
2022-07-06
Active, closed
Observational Study in Multiple System Atrophy
NCT05453058Multiple System Atrophy
H. Lundbeck A/S
Observational
90
Beijing, Changsha, Chengdu, Shanghai, Suzhou
2022-06-25
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2/3
124
Suzhou
2022-06-25
Active, closed
Intracranial Arterial Stenosis in Young Patients
NCT05844176Intracranial Arterial Stenosis
Capital Medical University
Observational
500
Suzhou, Shijiazhuang, Beijing, Zhengzhou
2022-06-01
Active, closed
The First Affiliated Hospital of Soochow University
Observational
1,000
Suzhou
2022-05-03
Recruiting
Urine and Ultrasound Screening for Kidney Disease in Children
NCT06018831Kidney Diseases, Diagnostic Techniques, Ultrasound, Urinalysis
Children's Hospital of Fudan University
Not applicable
13,000
Nantong, Suzhou
2022-04-12
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
28
Suzhou
2022-04-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Hefei, Beijing, Fuzhou, Harbin, Zhengzhou, Wuhan, Changsha, Suzhou
2022-03-24
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
92
Suzhou
2022-03-01
Recruiting
Sanofi
Phase 3
284
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wuhan
2022-02-15
Recruiting
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
NCT05334823Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd
Phase 2
100
Beijing, Chongqing, Shenzhen, Wuhan, Changsha, Nanjing, Suzhou, Nanchang
2022-01-26
Recruiting
Hrain Biotechnology Co., Ltd.
Early Phase 1
7
Suzhou
2022-01-26
Active, closed
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
50
Beijing, Fuzhou, Guangzhou, Wuhan, Changsha, Zhengzhou, Nanjing, Suzhou
2022-01-26
Recruiting
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Ascentage Pharma Group Inc.
Phase 2
75
Guangzhou, Haikou, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin, Hanzhou
2021-12-28
Active, closed
Takeda
Observational
72
Hefei, Beijing, Zhengzhou, Hohhot, Suzhou, Nanchang, Shenyang, Qingdao
2021-10-29
Active, closed
Beeline Medicines Corporation
Phase 2
248
Beijing, Shenzhen, Nanjing, Suzhou, Changchun, Dalian, Jinan, Jining
2021-10-11
Active, closed
PharmaEssentia
Phase 2
49
Beijing, Changsha, Chongqing, Guangzhou, Hefei, Shanghai, Shenzhen, Suzhou
2021-10-08
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 3
405
Guangzhou, Shenzhen, Zhengzhou, Wuhan, Nanjing, Suzhou, Xian, Chengdu
2021-10-06
Recruiting
Light Therapy in Parkinson's Disease
NCT06129942Parkinson Disease, Sleep Disorder, Circadian Rhythm Disorders
Second Affiliated Hospital of Soochow University
Not applicable
50
Suzhou
2021-09-01
Active, closed
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NCT05029141Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML
The First Affiliated Hospital of Soochow University
Phase 2
21
Suzhou
2021-09-01
Active, closed
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site, Genital Neoplasms, Female
Wenjun Cheng
Phase 2
56
Huai'an, Nanjing, Suzhou, Wuxi, Yancheng
2021-08-24
By invitation
Huashan Hospital
Observational
1,000
Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Wuhan, Nanjing, Suzhou
2021-08-01
By invitation
UCB Biopharma SRL
Phase 3
760
Beijing, Changchun, Guangzhou, Guilin, Shanghai, Shantou, Suzhou, Tianjin
2021-07-27
Active, closed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
45
Hefei, Guangzhou, Nanning, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Tianjin
2021-06-25
Active, closed
Akeso
Phase 1/2
136
Suzhou
2021-06-18
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
BeOne Medicines
Phase 1/2
260
Beijing, Lanzhou, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Suzhou, Nanchang
2021-05-24
Recruiting
Sellas Life Sciences Group
Phase 1/2
160
Bengbu, Hefei, Chongqing, Guangzhou, Baoding, Zhengzhou, Suzhou, Nanchang
2021-05-10
Recruiting
Shanghai Juncell Therapeutics
Early Phase 1
50
Suzhou
2021-05-06
Active, closed
Takeda
Phase 3
77
Beijing, Wuhan, Suzhou, Tianjin
2021-04-14
Active, closed
Karyopharm Therapeutics Inc
Phase 2
112
Beijing, Wuhan, Nantong, Suzhou, Changchun, Hangzhou
2021-03-17
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Beijing, Guangzhou, Hangzhou, Jinan, Kunming, Lanzhou, Suzhou
2021-02-23
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Beijing, Guangzhou, Hangzhou, Suzhou, Tianjin, Xi'an
2021-02-01
Active, closed
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
NCT04826705Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
2,000
Wuhan, Beijing, Chengdu, Hangzhou, Qingdao, Shanghai, Suzhou
2021-02-01
Active, closed
Amgen
Phase 1/2
181
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Qingdao, Xi’an
2021-01-04
Recruiting
Relationship Between "FODMAPs" and "GVHD"
NCT04660487Graft Versus Host Disease
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2020-12-01
Recruiting
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT05620095Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Beijing, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu, Hangzhou
2020-12-01
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Recruiting
Ascentage Pharma Group Inc.
Phase 1/2
682
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2020-09-28
Active, closed
AbbVie
Phase 3
531
Beijing, Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Suzhou
2020-09-10
Active, closed
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
NCT05395533CD20-positive B-cell Non-Hodgkin Lymphoma
DrugTRS005
Zhejiang Teruisi Pharmaceutical Inc.
Phase 1
147
Beijing, Guangzhou, Zhengzhou, Suzhou, Tianjin
2020-09-08
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Nanjing, Suzhou, Huangpu, Xuhui, Chengdu, Hangzhou
2020-09-03
Active, closed
First Affiliated Hospital of Zhejiang University
Phase 3
232
Changsha, Chongqing, Hangzhou, Nanjing, Ningbo, Suzhou
2020-09-01
Recruiting
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study
NCT04544527Diabetes Mellitus, Cardiovascular Diseases, Complication Diabetic
Shanghai Zhongshan Hospital
Observational
10,000
Suzhou
2020-09-01
Active, closed
PharmaEssentia
Phase 3
174
Beijing, Chongqing, Guangzhou, Wuhan, Suzhou, Shenyang, Xi'an, Jinan
2020-08-25
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
37
Suzhou
2020-01-19
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
31
Suzhou
2020-01-01
Active, closed
Pfizer
Phase 3
1,068
Hefei, Beijing, Fuzhou, Wuhan, Changsha, Nanjing, Nantong, Suzhou
2019-12-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Beijing, Tianjin, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Suzhou
2019-11-13
Active, closed
Sanofi
Observational
1,860
Beijing, Changsha, Chongqing, Guangzhou, Harbin, Shanghai, Shenzhen, Suzhou
2019-08-15
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1/2
50
Suzhou
2019-07-15
Active, closed
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
NCT03932136Clinical High Risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine
Phase 3
300
Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin
2019-07-14
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2019-07-01
Active, closed
SyMap Medical (Suzhou), Ltd.
Not applicable
160
Beijing, Guangzhou, Shenzhen, Shijiazhuang, Qiqihar, Nanjing, Suzhou, Xuzhou
2019-06-18
Recruiting
Eli Lilly and Company
Phase 3
190
Beijing, Chongqing, Nanjing, Suzhou
2019-04-05
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou, Changchun
2018-12-07
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Fuzhou, Haikou, Zhengzhou, Changsha, Hengyang, Suzhou, Wuxi, Hangzhou
2018-11-28
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Takeda
Phase 3
245
Zhengzhou, Suzhou, Changchun, Hangzhou, Tianjin
2018-10-04
Recruiting
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
NCT04146870Nutrition, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Observational
200
Suzhou
2018-10-01
Recruiting
Fudan University
Not applicable
4,052
Guiyang, Suzhou, Dalian, Shanghai
2018-07-01
Active, closed
The First Affiliated Hospital of Soochow University
Phase 1/2
43
Suzhou
2018-02-20
Active, closed
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
NCT03984968Acute Lymphoblastic Leukemia, Adult B-Cell
DrugCD19
The First Affiliated Hospital of Soochow University
Phase 1/2
40
Suzhou
2017-07-10
Recruiting
FMT in Gut aGVHD Treated
NCT03148743Acute-graft-versus-host Disease
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2017-05-16
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1/2
10
Suzhou
2016-09
Active, closed
Shanghai Jiao Tong University School of Medicine
Phase 3
786
Fuding, Fuzhou, Quanzhou, Foshan, Guangzhou, Harbin, Jiangyin, Suzhou
2016-03
Active, closed
CAR-T Cell Therapy Targeting to CD19 for R/R ALL
NCT03919240Acute Lymphoblastic Leukemia With Failed Remission
The First Affiliated Hospital of Soochow University
Phase 1/2
196
Suzhou
2015-12-01
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
539
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shanxi, Suzhou
2013-09-09
By invitation
Follow-up Study of ICUS and CCUS Patients
NCT04428489Myelodysplastic Syndromes
The First Affiliated Hospital of Soochow University
Observational
300
Suzhou
2011-01-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
20,000
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2008-01
Rows per page Showing 1–427 of 427
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 427 of those studies with a site in Suzhou.

How many clinical trials are recruiting in Suzhou?

273 of the 427 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 53 have not yet opened recruitment, 89 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suzhou), 427 studies
PhaseStudiesRecruitingShare
Not applicable855819.9%
Phase 2835519.4%
Phase 3784218.3%
Observational593313.8%
Phase 1463710.8%
Phase 1/238278.9%
Early Phase 11393%
Phase 2/31353%
Phase 41272.8%

Most active sponsors

Lead sponsors with the most studies (Suzhou)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University11580
Second Affiliated Hospital of Soochow University1611
Capital Medical University95
Novartis Pharmaceuticals83
Takeda74
Wecare Probiotics Co., Ltd.76
AbbVie61
Amgen61
Children's Hospital of Soochow University65
BeOne Medicines55
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.